Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$31,822,079
+$7,911,739 QoQ
Shares Held
26,531
+2.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#693
of 4,605 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $87,152,887 across 10 Drug Manufacturers - General names. LLY ranks #1 (36.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
26,531 | $31,822,079 | |
| 2 | ABBV |
AbbVie Inc.
|
85,535 | $21,524,027 | |
| 3 | JNJ |
Johnson & Johnson
|
43,298 | $10,996,393 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
59,347 | $7,497,899 | |
| 5 | MRK |
Merck & Co., Inc.
|
51,784 | $6,654,244 | |
| 6 | AMGN |
Amgen Inc
|
15,621 | $5,656,676 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,475 | $1,006,909 | |
| 8 | PFE |
Pfizer Inc
|
40,733 | $980,850 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,822,079 | 26,531 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $23,910,340 | 25,996 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $23,092,725 | 21,488 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $17,081,281 | 22,387 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $14,174,973 | 18,184 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,473,423 | 18,735 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $12,252,412 | 15,871 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,005,825 | 15,809 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $11,316,344 | 12,499 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $9,937,661 | 12,774 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,289,414 | 12,505 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $6,281,735 | 11,695 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,062,239 | 2,265 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $365,055 | 1,063 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $823,871 | 2,252 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $768,279 | 2,376 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $408,529 | 1,260 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $387,172 | 1,352 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $548,296 | 1,985 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $279,339 | 1,209 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $269,915 | 1,176 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $212,040 | 1,135 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||